Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,841 across all filing types
Latest filing 2025-11-24 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
独立董事年报工作制度（2025年11月）
Governance Information Classification · 95% confidence The document is titled '独立董事年报工作制度' which translates to 'Independent Directors Annual Report Work System'. It outlines the responsibilities and procedures for independent directors in relation to the company's annual report preparation and disclosure. The content focuses on governance, internal control, and the role of independent directors in overseeing the annual report process, including communication with auditors and shareholders. There is no actual financial data or audit results presented, nor is this a report or announcement of financial results. Instead, it is a governance-related document detailing internal rules and procedures for independent directors concerning the annual report. Therefore, the document fits best under Governance Information (CGR). The document length is short (1209 characters), and it is not an announcement of a report publication but a policy document. Hence, the classification is CGR with high confidence.
2025-11-24 Chinese
董事会秘书工作细则（2025年11月）
Governance Information Classification · 100% confidence The document is titled '董事会秘书工作细则' which translates to 'Board Secretary Work Rules'. It details the qualifications, duties, appointment, and responsibilities of the company's board secretary. It references relevant laws and regulations, and outlines internal governance procedures related to the board secretary's role. There is no financial data, earnings information, or report publication. The content is focused on governance practices and internal rules regarding the board secretary's function. Therefore, this document fits best under Governance Information (CGR). The document length is sufficient and it is not a mere announcement or certification, so it is not RPA or RNS.
2025-11-24 Chinese
对外担保管理制度（2025年11月）
Governance Information Classification · 95% confidence The document is titled '对外担保管理制度' which translates to 'External Guarantee Management System' and is a detailed internal policy document of the company regarding the management, approval, supervision, and disclosure of external guarantees. It includes references to company laws, securities laws, board and shareholder meeting approvals, risk control, and disclosure obligations. It is a governance and compliance related internal regulation document rather than a financial report, earnings release, or announcement. It does not contain financial statements or audit results, nor is it a notice or announcement of a report. It is a governance-related document detailing internal rules and procedures for external guarantees. Therefore, the most appropriate classification is Governance Information (CGR).
2025-11-24 Chinese
会计师事务所选聘制度（2025年11月）
Governance Information Classification · 95% confidence The document is titled '健帆生物科技集团股份有限公司 会计师事务所选聘制度' which translates to 'JH Biotech Group Co., Ltd. Auditor Selection System'. It details the policies, procedures, and requirements for selecting and appointing accounting firms (auditors) for the company. The content includes governance rules, audit committee responsibilities, selection criteria, and supervisory and penalty measures related to auditor appointment. There is no financial data, audit results, or report content. It is a governance or procedural document related to auditor selection rather than an audit report or annual report. It does not announce a report publication but sets internal rules and procedures. Therefore, it fits best under Governance Information (CGR), which covers internal rules and governance practices.
2025-11-24 Chinese
董事会薪酬与考核委员会议事规则（2025年11月）
Governance Information Classification · 95% confidence The document is titled '董事会薪酬与考核委员会议事规则' which translates to 'Board of Directors Remuneration and Assessment Committee Rules'. It details the structure, responsibilities, meeting procedures, and governance related to the board's remuneration and assessment committee. There are no financial statements, earnings data, or regulatory filings. The content focuses on governance practices, internal rules, and committee operations related to compensation and assessment of directors and senior management. This matches the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices. The document length is 4317 characters, which is sufficient for a detailed governance report rather than a brief announcement or certification. Therefore, the appropriate classification is CGR with high confidence.
2025-11-24 Chinese
董事会审计委员会年报审议工作规则（2025年11月）
Audit Report / Information Classification · 95% confidence The document is titled '审计委员会年报审议工作规则' which translates to 'Audit Committee Annual Report Review Working Rules'. It outlines the responsibilities, procedures, and rules for the audit committee in reviewing the company's annual report. The content focuses on governance and internal control mechanisms related to the annual report process, rather than presenting the annual report itself or its financial data. The document is relatively short (1172 characters) and is a procedural or governance document related to the audit committee's role in the annual report process. Therefore, it fits best under 'Audit Report / Information (AR)' as it pertains to audit committee rules and audit report review procedures, but is not the annual report itself.
2025-11-24 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.